BSCFX | NRGEX | BSCFX / NRGEX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 27 years | 3 years | - |
Gain YTD | 4.403 | 2.335 | 189% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 4.34B | 10.5B | 41% |
Annual Yield % from dividends | 0.00 | 0.89 | - |
Returns for 1 year | 5.41 | 13.78 | 39% |
Returns for 3 years | -3.96 | -2.76 | 143% |
Returns for 5 years | 3.14 | N/A | - |
Returns for 10 years | -3.28 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SFEPX | 20.43 | 0.19 | +0.94% |
NAA Large Core P | |||
PCBAX | 14.75 | 0.03 | +0.20% |
BlackRock Tactical Opportunities Inv A | |||
PQSCX | 24.99 | 0.02 | +0.08% |
Virtus KAR Small-Cap Value C | |||
ECASX | 28.97 | -0.02 | -0.07% |
Eaton Vance Atlanta Capital SMID-Cap C | |||
LYFCX | 12.39 | -0.10 | -0.80% |
AlphaCentric Life Sciences & Hlthcare C |